Tag: Chemotherapy
Neoadjuvant Chemotherapy Key to Survival in Pancreatic Cancer
Three factors independently linked to prolonged survival in BR/LA pancreatic ductal adenocarcinoma
AACR: Longer Survival With Gilteritinib in FLT3mut+ AML
Longer overall survival, better remission rates seen for patients receiving gilteritinib versus salvage chemo
Docetaxel Chemo Ups Survival in High-Risk Localized Prostate Cancer
Findings based on addition of docetaxel chemotherapy to androgen suppression, radiotherapy
Taxane + Platinum Feasible for Adjuvant Tx in Endometrial Cancer
Tolerability, survival similar to that for doxorubicin + cisplatin for postoperative adjuvant chemotherapy
Radiomic Features May Predict Response to Chemo in NSCLC
Peritumoral, intratumoral radiomic features on baseline CT scans may predict chemo response
Brachytherapy Boost Ups Survival in Locally Advanced Cervical Cancer
Findings observed regardless of treatment duration; disparities for brachytherapy use seen in vulnerable populations
FDA OKs Tecentriq for Extensive-Stage Small Cell Lung Cancer
Drug now approved as first-line treatment to be used in combination with carboplatin and etoposide
FDA Approves First Immunotherapy Drug for Breast Cancer
Combo of Tecentriq and chemo given accelerated approval for triple-negative breast cancer
Long-Term Cardiomyopathy Risk Varies by Chemo Agent
Decreased risk seen for daunorubicin versus doxorubicin among survivors of childhood cancer
Chemo-Radiation Combo Tied to Higher Survival in Peds Hodgkin
Five-year overall survival higher in patients who receive combined tx than those treated with chemo alone
